In addition AFs have been associated with newborn jaundice (NNJ), although recent epidemiologic studies report no significant evidence for a link between NNJ and exposure to AFs reported that breast milk samples obtained from 388 Egyptian women were found to contain AFM1 with detectable levels in about 36% of samples. This is of interest
since a consequence of early exposure to AFs is growth impairment. Cross-sectional studies found that a dose response link between AF exposure and underweight is present in West African young children under 5 years old. The daily intakes of AFM1 were in the range of 0.08e0.021 ng/kg b.w. studied the correlation between AFM1 amounts in breast milk, dietary exposure to AFB1 and socioeconomic status of lactating mothers in Nigeria. AFM1 occurred in 82% of the breast
milk samples (3.49e35 ng/l) and 16% exceeded the EU limit of 25 ng/l. The socioeconomic status of the mothers was significantly and negatively correlated to their dietary exposure. A screening study in
infant formula milks was carried out in Italy. The authors found that 1% out of 185 samples contained detectable levels of AFM1 at the range of 11.8e15.3 ng/l determined the mycoflora and AFs in 84 samples of baby food
commercially available in North Africa. They reported that 45.8% of the isolates were found to be mycotoxigenic, but only 2.4% of the samples contained AFs at mean levels between 19 and 70 mg/kg.